摘要
目的:探讨控制血压对中老年男性高血压患者国际前列腺增生症状评分(IPSS)和最大尿流率(Qmax)的影响。方法:收集安徽安庆农村地区50~75岁男性原发性高血压患者193例,连续4周服用长效二氢吡啶类L型钙离子通道阻滞剂氨氯地平,观察基线血压水平及血压下降水平对IPSS和Qmax的影响。结果:4周后研究人群收缩压和舒张压分别下降了(16.8±16.7)、(8.1±7.7)mmHg(P<0.01);IPSS下降了(2.5±5.5)分(P<0.01),Qmax增加了(0.2±4.7)ml/s(P=0.46)。Qmax变化水平与基线血压及血压变化水平没有显著性差异。IPSS下降水平与血压下降水平没有显著性差异,但与基线血压水平有显著性差异。结论:在中老年男性高血压人群中,控制血压有利于预防和减轻BPH的主观症状。基线血压水平越高,BPH的主观症状经过降压治疗后改善越明显。
Objective: To explore the influence of blood pressure lowering treatment on the International Prostate Syndrome Score (IPSS) and maximum flow rate (Qmax) in old and middle-aged male patients with essential hypertension. Methods: We enrolled 193 hypertensive male patients aged 50 -75 years from the rural area of Anqing, Anhui, treated them with Amlodipine for 4 weeks, and then analyzed the correlation of their baseline blood pressure and reduced blood pressure with the changes of IPSS and Qmax. Results: After 4 weeks of medication, the systolic blood pressure (SBP) and diastolic blood pressure (DBP) of the subjects dropped by 16.8 ± 16.7 and 8.1 ±7.7 mmHg respectively (P 〈 0.01), IPSS decreased by 2.5 ±5.5 points (P 〈 0.01) and Qmax increased by 0.2 ± 4.7 ml/s ( P = 0.46 ). Changes of Qmax were not significantly correlated with either the baseline or decreased blood pressure, while changes of IPSS had a significant linear correlation with the former but not with the latter. Conclusion : Lowering blood pressure in old and middle-aged male patients with essential hypertension can prevent or alleviate the subjective symptoms of benign prostatic hyperplasia, and it reduces IPSS more significantly in those with higher baseline blood pressure.
出处
《中华男科学杂志》
CAS
CSCD
北大核心
2009年第7期632-635,共4页
National Journal of Andrology
关键词
高血压
国际前列腺增生症状评分
最大尿流率
良性前列腺增生
hypertension
International Prostate Syndrome Score
maximum flow rate
benign prostatic hyperplasia